OptiCare Health Systems, Inc. in Acquisition Discussions With Refac WATERBURY, Conn., April 8 /PRNewswire-FirstCall/ -- OptiCare Health Systems, Inc. (AMEX:OPT) announced today that Refac (AMEX:REF), an affiliated company, has expressed interest in exploring an acquisition of OptiCare in a stock transaction and that OptiCare and Refac have entered into discussions regarding same. Refac also announced today that it has entered into acquisition discussions with U.S. Vision, Inc., another affiliated company, which is privately-held and operates the 6th largest retail optical chain in the United States. OptiCare, Refac and U.S. Vision are all controlled by Palisade Concentrated Equity Partnership, L.P. ("Palisade"), which beneficially owns approximately 84% of OptiCare's outstanding common stock (on a fully diluted basis), 90% of Refac's outstanding common stock and 88% of U.S. Vision's outstanding common stock. Refac was incorporated in 1952 and for most of its history, was engaged in intellectual property licensing activities. During the period from 1997 to 2002, it was also engaged in the business of product development and graphic design and had invested these creative resources, together with its licensing skills, in certain product development ventures. In March 2002, Refac announced plans to reposition itself for sale or liquidation and by the end of 2002, it had disposed of all of its operating segments with the exception of its licensing business and it has limited the operations of that segment to managing certain existing license agreements and related contracts. On February 28, 2003, Refac completed a merger with a wholly-owned subsidiary of Palisade pursuant to which Palisade acquired control of Refac and, in May 2003, Palisade increased its ownership to approximately 90% through an additional cash investment of $17 million. Palisade had indicated that it intended to use Refac as a vehicle for making acquisitions and the purpose of the stock purchase transaction was to provide Refac with additional capital for making these acquisitions. As of December 31, 2004, Refac reported a net worth of $31,197,000 with approximately $29,000,000 available for acquisitions. U.S. Vision, a privately held company, is a leading store-within-a-store retailer of optical products and services with net revenues of approximately $128 million during its most recent fiscal year. It operates 518 locations in 47 states and Canada, consisting of 506 licensed departments and 12 freestanding stores. "We are very excited about the possibility of combining these companies," said a representative of Palisade. "We are committed to the retail optical business through our control positions in OptiCare and U.S. Vision and believe that both of these companies have good potential for organic growth, which will be enhanced by Refac's strong financial condition. In addition to OptiCare's and U.S. Vision's growth possibilities, the consolidation in the retail optical industry presents an opportunity for additional growth through acquisition. Finally, we know the management of all three companies and believe that they will work together to take advantage of the cost savings made possible through this combination." Christopher J. Walls, OptiCare's President and Chief Executive Officer, stated that "OptiCare's Board of Directors has formed an independent committee to consider, evaluate and negotiate the potential transaction and then make a recommendation to the Board." About OptiCare Health Systems, Inc. OptiCare Health Systems, Inc. is an integrated eye care services company focused on vision benefits management and consumer vision services, including medical, surgical and optometric services and optical retail. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This News Release includes certain statements of the Company that may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and which are made pursuant to the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning the potential transaction with Refac, as well as plans, objectives, goals, strategies, future events, or performance, and any underlying assumptions and statements that are not statements of historical fact. When used in this News Release, the words "expects," "anticipates," "estimates," "plans," "intends," "projects," "predicts," "believes," "may" or "should," and similar expressions, are intended to identify forward-looking statements. These forward-looking statements based upon the beliefs of management and assumptions made by and information currently available to the Company. These statements reflect the current view of the Company's management with respect to future events. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements, including, but not limited to, the Company's ability to come to acceptable terms with Refac or, if it does come to terms, that Refac's acquisition of the Company will prove to be beneficial for the Company and its stockholders. Investors are cautioned that all forward-looking statements involve those risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2004. Forward-looking statements speak only as of the date they are made and the Company undertakes no duty or obligation to update any forward-looking statements in light of new information or future events. DATASOURCE: OptiCare Health Systems, Inc. CONTACT: William A. Blaskiewicz, CFO of OptiCare Health Systems, Inc., +1-203-596-2236

Copyright

Opticare Health (AMEX:OPT)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Opticare Health Charts.
Opticare Health (AMEX:OPT)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Opticare Health Charts.